Amphastar Pharma (AMPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 66,074 | 67,828 | 53,587 | 50,213 | 0 |
| Marketable Securities | 1,285 | 1,495 | 1,325 | 1,888 | 0 |
| Receivables | 33,471 | 23,125 | 27,014 | 38,275 | 0 |
| Inventories | 70,665 | 82,332 | 69,916 | 51,378 | 0 |
| Income taxes - deferred | N/A | 19,533 | 16,096 | 20,301 | N/A |
| TOTAL | $175,934 | $197,996 | $172,971 | $165,690 | $0 |
| Non-Current Assets | |||||
| PPE Net | 142,161 | 138,289 | 116,619 | 107,366 | 0 |
| Other Non-Current Assets | 72,041 | 53,085 | 49,158 | 44,421 | 0 |
| TOTAL | $214,202 | $191,374 | $165,777 | $151,787 | $N/A |
| Total Assets | $390,136 | $389,370 | $338,748 | $317,477 | $0 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 10,934 | 7,594 | 22,104 | 22,052 | 0 |
| Accounts payable and accrued liabilities | 13,872 | 10,161 | 20,380 | 17,663 | 0 |
| Accrued Expenses | 31,430 | 26,511 | 19,428 | 16,686 | 0 |
| TOTAL | $59,955 | $62,595 | $65,402 | $60,075 | $0 |
| Non-Current Liabilities | |||||
| Long Term Debt | 30,165 | 36,106 | 10,069 | 15,950 | 0 |
| Deferred Revenues | 643 | 14,013 | 643 | 642 | N/A |
| Other Non-Current Liabilities | 3,167 | 989 | 1,953 | 1,660 | 0 |
| TOTAL | $34,671 | $44,915 | $21,801 | $23,963 | $N/A |
| Total Liabilities | $94,626 | $107,510 | $87,203 | $84,038 | $0 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 44,914 | 44,565 | N/A | N/A | N/A |
| Common Shares | 5 | 4 | 4 | 4 | 0 |
| Retained earnings | 60,323 | 63,110 | 73,809 | 61,947 | 0 |
| Other shareholders' equity | -2,647 | -1,999 | 0 | 0 | 0 |
| TOTAL | $295,510 | $281,860 | $251,545 | $233,439 | $0 |
| Total Liabilities And Equity | $390,136 | $389,370 | $338,748 | $317,477 | $0 |